Sign In
Buy MS
$220.83
+2.76 (+1.27%)
At Close: Jun 16, 2026
7 Blue-Chip Stocks to Buy for a Market Pullback
05:08pm, Wednesday, 06'th Sep 2023
After a blistering first half of the year, the outlook for the stock market has gotten murky. All three major U.S. indices declined in August, with the Dow Jones Industrial Average falling 2.4%, the N
Debt-laden Altice in talks to sell data centres to Morgan Stanley - Les Echos
01:07pm, Wednesday, 06'th Sep 2023
Cable and telecoms group Altice is nearing a deal to sell its data centres in France to Morgan Stanley Infrastructure Partners, Les Echos reported on Wednesday, as the group of French-Israeli billiona
3 Investment Bank Stocks Watch as Industry Navigates Challenges
11:18am, Wednesday, 06'th Sep 2023
Though near-erm concerns remain, the Zacks Investment Bank industry sees green shoots in underwriting and advisory businesses. This, along with decent trading, will aid companies like Morgan Stanley (
3 Companies Committed to Boosting Shareholder Value
07:32pm, Tuesday, 05'th Sep 2023
Stock buybacks, or share repurchase programs, are commonly executed by companies to boost shareholder value.
Why Investors Dimmed on Lumen Techologies Stock Today
06:54pm, Tuesday, 05'th Sep 2023
An analyst took a pair of scissors to his price target on the struggling telecom's shares. Actually, it felt more like a set of garden shears, considering how big a whack he took.
My Top 10 High Yield Dividend Stocks For September 2023
12:09pm, Sunday, 03'rd Sep 2023
August saw a wave of volatility in equity markets, with the SPDR S&P Trust ETF falling by 1.63%. My top 10 list of high dividend yield stocks has generated an annualized rate of return of 12.71% since
Dividend Harvesting Portfolio Week 130: $13,000 Allocated, $1,112.40 In Projected Dividends
08:45am, Thursday, 31'st Aug 2023
The Dividend Harvesting Portfolio finished its 9th consecutive week in the black, with a 1.4% increase in invested capital. Medical Properties Trust slashed its dividend by approximately 50%, becoming
Asset managers and hedge funds are increasingly taking different positions in the U.S. Treasury market
01:54pm, Wednesday, 30'th Aug 2023
Asset managers and hedge funds are increasingly taking different positions inside the most liquid government-securities market in the world — and the gulf has only gotten wider this month.
Mike Mayo Sees 'Gut Punch' for Biggest Banks in Basel III Endgame
02:48pm, Tuesday, 29'th Aug 2023
Veteran analyst Mike Mayo, a managing director at Wells Fargo, says larger banks should prepare for a "punch to the stomach" from the stricter capital requirements contained in the Basel III Endgame p
Buyback Boosters: 3 Stocks Primed for Gains After Repurchase Moves
05:50am, Tuesday, 29'th Aug 2023
In 2022, U.S. companies did $1.22 trillion in stock buybacks. In the first half of 2023, S&P 500 companies have repurchased $385 billion in stock despite paying over $3 billion in tax on the share rep
Databricks could be valued at $43BN in new funding round, report says
12:43pm, Monday, 28'th Aug 2023
Databricks Inc is in talks to raise fresh funding that values the company at $43 billion, according to a report on Bloomberg. The US-based artificial intelligence (AI) has engaged investment managemen
Is Most-Watched Stock Morgan Stanley (MS) Worth Betting on Now?
10:32am, Monday, 28'th Aug 2023
Recently, Zacks.com users have been paying close attention to Morgan Stanley (MS). This makes it worthwhile to examine what the stock has in store.
S&P Downgrades 5 Banks: What Does It Mean For The Market?
08:26am, Friday, 25'th Aug 2023
A look at the Financial Select Sector SPDR Fund NYSEARCA: XLF chart, you'll see financials aren't exactly being pummeled after S&P's downgrade of five bank stocks.
Biogen stock slips after FDA approves first biosimilar to Tysabri MS treatment
06:07pm, Thursday, 24'th Aug 2023
Biogen Inc. BIIB, -0.90% shares slipped in the extended session Thursday after the Food and Drug Administration granted a soon-to-be Novartis AG NVS, -1.94% spinoff approval for the first biosimilar t
Goldman Sachs, Morgan Stanley, JPMorgan, and UBS to pay $499M in stock lending settlement
11:35am, Thursday, 24'th Aug 2023
Goldman Sachs (NYSE:GS) Group Inc, Morgan Stanley (NYSE:MS), JPMorgan Chase & Co (NYSE:JPM) and UBS AG have agreed to pay $499 million to settle an antitrust class action by US pension funds over th
